Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non–Small-Cell Lung Cancer

Abdul Rafeh Naqash, Hirva Mamdani, Luis E. Raez et al.|JCO Precision Oncology|2024

Cited by 5